In this episode of Take Once a Week, we will discuss the approval of Biogen's Aduhelm as well as some of the major discussions that occurred this past week at ASCO. If you like this episode and others like it, be sure to subscribe!
 
LINKS TO ALL STORIES:
<ul>
 <li><a href="https://www.biopharmadive.com/news/biogen-aduhelm-confirmatory-study-fda-approval/601422/">https://www.biopharmadive.com/news/biogen-aduhelm-confirmatory-study-fda-approval/601422/ 
</a></li>
 <li><a href="https://www.biopharmadive.com/news/a-first-of-its-kind-alzheimers-drug-raises-heavy-questions-around-who-will/601434/">https://www.biopharmadive.com/news/a-first-of-its-kind-alzheimers-drug-raises-heavy-questions-around-who-will/601434/ 
</a></li>
 <li><a href="https://www.biopharmadive.com/news/asco-2021-takeaways-adjuvant-immunotherapy-fate-cullinan/601384/">https://www.biopharmadive.com/news/asco-2021-takeaways-adjuvant-immunotherapy-fate-cullinan/601384/ 
</a></li>
 <li>https://www.fiercepharma.com/pharma/1-2b-deal-for-molnupiravir-u-s-bets-merck-to-finally-provide-effective-covid-19-treatment 
</li>
</ul>
#pharmacy #news #pharma #pharmaupdates #podcast #academic #vaccine #alzheimers #developments

Take Once a Week July 07: Scorpion and Jardiance

Weekly pharmacy news recaps. This podcast covers all important news in the world of pharmacy for the layman and pharmacist alike. 

Free from opinion and bias, we provide you with the most up-to-date and accurate information available from a variety of news sources.

Episodes are posted weekly on Wednesdays or Thursdays

DISCLAIMER: All opinions are my own and are not the views of my employer(s).